BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8692967)

  • 1. Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase.
    Sharma A; Okabe J; Birch P; McClellan SB; Martin MJ; Platt JL; Logan JS
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7190-5. PubMed ID: 8692967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic expression of human alpha1,2-fucosyltransferase (H-transferase) prolongs mouse heart survival in an ex vivo model of xenograft rejection.
    Chen CG; Salvaris EJ; Romanella M; Aminian A; Katerelos M; Fisicaro N; d'Apice AJ; Pearse MJ
    Transplantation; 1998 Mar; 65(6):832-7. PubMed ID: 9539096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined transgenic expression of alpha-galactosidase and alpha1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galalpha(1,3)Gal.
    Osman N; McKenzie IF; Ostenried K; Ioannou YA; Desnick RJ; Sandrin MS
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14677-82. PubMed ID: 9405672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of Gal-alpha1,3Gal epitope on xenogeneic lines: implications for cellular gene therapy based on the encapsulation technology.
    Déglon N; Aubert V; Spertini F; Winkel L; Aebischer P
    Xenotransplantation; 2003 May; 10(3):204-13. PubMed ID: 12694540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cell surface glycosylation in alpha1,3-galactosyltransferase knockout and alpha1,2-fucosyltransferase transgenic mice.
    Shinkel TA; Chen CG; Salvaris E; Henion TR; Barlow H; Galili U; Pearse MJ; d'Apice AJ
    Transplantation; 1997 Jul; 64(2):197-204. PubMed ID: 9256173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type II activation.
    Palmetshofer A; Galili U; Dalmasso AP; Robson SC; Bach FH
    Transplantation; 1998 Apr; 65(7):971-8. PubMed ID: 9565103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of Gal alpha(1,3)Gal expression by alpha1,2-fucosyltransferase: further characterization of alpha1,2-fucosyltransferase transgenic mice.
    Cohney S; McKenzie IF; Patton K; Prenzoska J; Ostenreid K; Fodor WL; Sandrin MS
    Transplantation; 1997 Aug; 64(3):495-500. PubMed ID: 9275118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of metastatic properties of BL6 melanoma cells expressing terminal fucose(alpha)1-2-galactose after alpha1,2-fucosyltransferase cDNA transfection.
    Gorelik E; Xu F; Henion T; Anaraki F; Galili U
    Cancer Res; 1997 Jan; 57(2):332-6. PubMed ID: 9000578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of alpha-1,3-galactose and other type 2 oligosaccharide structures in a porcine endothelial cell line transfected with human alpha-1,2-fucosyltransferase cDNA.
    Sepp A; Skacel P; Lindstedt R; Lechler RI
    J Biol Chem; 1997 Sep; 272(37):23104-10. PubMed ID: 9287311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of alpha 1,3-galactosyltransferase-knockout cloned pigs expressing human alpha 1,2-fucosylosyltransferase.
    Ramsoondar JJ; Macháty Z; Costa C; Williams BL; Fodor WL; Bondioli KR
    Biol Reprod; 2003 Aug; 69(2):437-45. PubMed ID: 12672664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis.
    Sandrin MS; Fodor WL; Mouhtouris E; Osman N; Cohney S; Rollins SA; Guilmette ER; Setter E; Squinto SP; McKenzie IF
    Nat Med; 1995 Dec; 1(12):1261-7. PubMed ID: 7489406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated expression of human secretor type alpha(1,2) fucosyltransferase reduces level of Gal alpha(1,3)Gal epitope.
    Xing L; Xia GH; Fei J; Bai XF; Guo LH
    Acta Pharmacol Sin; 2000 Sep; 21(9):807-13. PubMed ID: 11501162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level porcine endothelial cell expression of alpha(1,2)-fucosyltransferase reduces human monocyte adhesion and activation.
    Kwiatkowski P; Artrip JH; Edwards NM; Lietz K; Tugulea S; Michler RE; McKenzie IF; Sandrin MS; Itescu S
    Transplantation; 1999 Jan; 67(2):219-26; discussion 193-4. PubMed ID: 10075584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated expression of antisense RNA transcripts complementary to pig alpha(1,3) galactosyltransferase mRNA inhibits expression of Gal alpha(1,3) Gal epitope.
    Xing L; Xia GH; Bai XF; Fei J; Guo LH
    Acta Pharmacol Sin; 2000 Nov; 21(11):1005-10. PubMed ID: 11501054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double transgenic pigs with combined expression of human α1,2-fucosyltransferase and α-galactosidase designed to avoid hyperacute xenograft rejection.
    Zeyland J; Woźniak A; Gawrońska B; Juzwa W; Jura J; Nowak A; Słomski R; Smorąg Z; Szalata M; Mazurek U; Lipiński D
    Arch Immunol Ther Exp (Warsz); 2014 Oct; 62(5):411-22. PubMed ID: 24554032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichostatin A-Assisted Epigenomic Modulation Affects the Expression Profiles of Not Only Recombinant Human α1,2-Fucosyltransferase and α-Galactosidase A Enzymes But Also Galα1→3Gal Epitopes in Porcine Bi-Transgenic Adult Cutaneous Fibroblast Cells.
    Wiater J; Samiec M; Skrzyszowska M; Lipiński D
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the human alpha1,2-fucosyltransferase in transgenic pigs modifies the cell surface carbohydrate phenotype and confers resistance to human serum-mediated cytolysis.
    Costa C; Zhao L; Burton WV; Bondioli KR; Williams BL; Hoagland TA; Ditullio PA; Ebert KM; Fodor WL
    FASEB J; 1999 Oct; 13(13):1762-73. PubMed ID: 10506579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of human alpha-galactosidase and alpha1,2-fucosyltransferase genes modifies the cell surface Galalpha1,3Gal antigen and confers resistance to human serum-mediated cytolysis.
    Jia Y; Ren H; Gao X; Ji S; Yang J; Liu Z; Li S; Zhang Y
    Chin Med Sci J; 2004 Mar; 19(1):31-7. PubMed ID: 15104222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning and characterization of a novel alpha 1,2-fucosyltransferase (CE2FT-1) from Caenorhabditis elegans.
    Zheng Q; Van Die I; Cummings RD
    J Biol Chem; 2002 Oct; 277(42):39823-32. PubMed ID: 12163507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic approaches for the reduction of Galalpha(1,3)Gal for xenotransplantation.
    Sandrin MS; Osman N; McKenzie IF
    Front Biosci; 1997 Apr; 2():e1-11. PubMed ID: 9159186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.